208 related articles for article (PubMed ID: 25925291)
1. Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study.
Yamazaki H; Todo Y; Mitsube K; Hareyama H; Shimada C; Kato H; Yamashiro K
J Gynecol Oncol; 2015 Jul; 26(3):214-21. PubMed ID: 25925291
[TBL] [Abstract][Full Text] [Related]
2. Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetate.
Nakayama K; Ishikawa M; Nagai Y; Yaegashi N; Aoki Y; Miyazaki K
Int J Clin Oncol; 2010 Apr; 15(2):179-83. PubMed ID: 20217451
[TBL] [Abstract][Full Text] [Related]
3. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
[TBL] [Abstract][Full Text] [Related]
4. Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.
Stewart LE; Beck TL; Giannakopoulos NV; Rendi MH; Isacson C; Goff BA
Gynecol Oncol; 2018 May; 149(2):297-300. PubMed ID: 29534832
[TBL] [Abstract][Full Text] [Related]
5. Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.
Alkasi O; Meinhold-Heerlein I; Zaki R; Fasching P; Maass N; Jonat W; Beckmann MW
Arch Gynecol Obstet; 2009 Jan; 279(1):57-60. PubMed ID: 18379806
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma.
Spano JP; Soria JC; Kambouchner M; Piperno-Neuman S; Morin F; Morere JF; Martin A; Breau JL
Med Oncol; 2003; 20(1):87-93. PubMed ID: 12665689
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study.
Dahhan T; Fons G; Buist MR; Ten Kate FJ; van der Velden J
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):80-4. PubMed ID: 19269732
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitor therapy for endometrial stromal sarcoma - two-centre experience.
Serkies K; Abacjew-Chmyłko A; Wieczorek-Rutkowska M; Pęksa R
Ginekol Pol; 2018; 89(11):607-610. PubMed ID: 30508212
[TBL] [Abstract][Full Text] [Related]
10. Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue.
Burke C; Hickey K
Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1182-4. PubMed ID: 15516445
[TBL] [Abstract][Full Text] [Related]
11. Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases.
Bai H; Yang J; Cao D; Huang H; Xiang Y; Wu M; Cui Q; Chen J; Lang J; Shen K
Gynecol Oncol; 2014 Mar; 132(3):654-60. PubMed ID: 24412112
[TBL] [Abstract][Full Text] [Related]
12. Hormonal therapy of endometrial stromal sarcoma.
Reich O; Regauer S
Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
[TBL] [Abstract][Full Text] [Related]
13. Endometrial stromal sarcoma: analysis of treatment failures and survival.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
[TBL] [Abstract][Full Text] [Related]
14. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
[TBL] [Abstract][Full Text] [Related]
15. Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study.
Zhou J; Zheng H; Wu SG; He ZY; Li FY; Su GQ; Sun JY
Int J Surg; 2015 Nov; 23(Pt A):147-51. PubMed ID: 26449652
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Leiser AL; Hamid AM; Blanchard R
Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
[TBL] [Abstract][Full Text] [Related]
17. Hormonal therapy with letrozole prior to surgical management of recurrent metastatic low-grade endometrial stromal sarcoma (LGESS).
Tzakas E; Liu S; Todd RW; Redman CW
J Obstet Gynaecol; 2009 Nov; 29(8):778-9. PubMed ID: 19821687
[No Abstract] [Full Text] [Related]
18. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma.
Cabrera S; Bebia V; Acosta U; Franco-Camps S; Mañalich L; García-Jiménez A; Gil-Moreno A
Clin Transl Oncol; 2021 Jun; 23(6):1210-1219. PubMed ID: 33210235
[TBL] [Abstract][Full Text] [Related]
19. Treatment of recurrent or metastatic low-grade endometrial stromal sarcoma: three case reports.
Garavaglia E; Pella F; Montoli S; Voci C; Taccagni G; Mangili G
Int J Gynecol Cancer; 2010 Oct; 20(7):1197-200. PubMed ID: 21495227
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy for endometrial stromal sarcomas: current treatment options.
Serkies K; Pawłowska E; Jassem J
Ginekol Pol; 2016; 87(8):594-7. PubMed ID: 27629136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
